PILs are based on the Summaries of Product Characteristics (SPCs) which are a description of a medicinal product’s properties and the conditions attached to its use. We publish the most...

2019年12月19日 · How to get information including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs). Healthcare …

Report a side effect with a medicine or medical device. Make a report. Loading results for ...

The new MHRA Safety Roundup provides a monthly summary of the latest safety advice for all medicines, medical devices, and healthcare products regulated by the MHRA, as part of our 3 …

公共评估报告 (PAR) 是一份科学评估报告，可用于 2005 年 10 月 30 日之后授予的营销授权。 该服务取代了以前独立的 MHRA 网站，其中一个网站托管 SPC 和 PIL，另一个 PAR。

2024年12月3日 · Following the implementation of the Windsor Agreement, a new framework is coming into effect in the new year affecting the UK licensing regime for medicinal products, …

Submission platform that supports Pharma in fulfilling their regulatory requirements to make their reference safety information as accessible as possible. The most up to date, comprehensive, …

2025年1月6日 · MAs granted by the UK’s human medicines regulator (the MHRA) had effect only in Great Britain, whereas centralised MAs granted by the European Medicines Agency (EMA) …

Report a side effect with a medicine or medical device. Make a report. Loading results for ...

2024年12月4日 · From 1st January 2025 the only route to a UK marketing authorisation for a human medicinal product will be an approval from the UK’s regulatory agency, the Medicines …